Article Text

other Versions

PDF
Letter
Propofol for sedation during less invasive surfactant administration in preterm infants
  1. Claire Sophie Descamps1,
  2. Marie Chevallier1,2,
  3. Anne Ego2,
  4. Isabelle Pin3,
  5. Chloé Epiard1,
  6. Thierry Debillon1,2,4
  1. 1 Neonatal Intensive Care Unit, CHU de Grenoble, Grenoble, 38 043 Grenoble Cedex 9, France
  2. 2 Grenoble Alps University, CNRS, TIMC-IMAG, UMR 5525 ThEMAS, Grenoble, France
  3. 3 Département de pédiatrie - Centre mucoviscidose, CHU de Grenoble, Hôpital Albert Michallon, Grenoble, France
  4. 4 Univ Grenoble Alpes, Grenoble, France
  1. Correspondence to Professor Thierry Debillon, Grenoble Alps University, CNRS, TIMC-IMAG, UMR 5525 ThEMAS, Grenoble, France; tdebillon{at}chu-grenoble.fr

Statistics from Altmetric.com

Less invasive surfactant administration (LISA) in preterm infants with respiratory distress syndrome avoids mechanical ventilation and may further reduce the risk of death or bronchopulmonary dysplasia.1 A recent European survey indicates that the percentage of centres using LISA increased, but with wide variation in procedure. In particular, there is no consensus about whether sedation should be used.2 International guidelines recommend sedation for intubation but it can hamper spontaneous breathing, which is necessary for LISA. Recently, a study compared two groups …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.